Ask AI

On-Demand Webcast

Share

Program Content

Activities

  • Overcoming Endocrine Resistance in HRpos HER2neg MBC
    Overcoming Endocrine Resistance in HR+/HER2- MBC: Tailoring Treatment for Patients With ESR1- and PI3K/AKT/PTEN-Altered Disease Post-ET Progression
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 20, 2025

    Expires: December 19, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, Lilly and Stemline Therapeutics, Inc.

AstraZeneca

Lilly

Stemline Therapeutics, Inc.